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Abstract 
NFIX is a transcription factor involved in the development of various organs 
among which the brain and the skeletal muscle. In the skeletal muscle, NFIX 
induces the switch from embryonic to fetal myogenesis and it regulates the 
regeneration process in the adult mouse. Considering that skeletal and 
cardiac muscle share several signaling pathways beyond the same 
mesodermal origin, here we investigated for the first time the expression 
profile and role of NFIX in the heart.  
We discovered that Nfix gene is barely expressed at early stages of heart 
development but its expression increases after birth until postnatal day 7. 
Histological analysis revealed no apparent morphological alterations Nfix-
null hearts when compared to WT littermates. In agreement with these data, 
no differences in the expression of the sarcomeric genes such as cardiac 
myosins (Myh6, Myh7, Mlc2v), troponin (cTnI) and of the transcription 
factor Nkx2.5 were found between WT and Nfix-null mice. In the adult heart, 
Nfix gene is highly expressed in both atria and ventricles but significantly 
less expressed in the sinoatrial node (SAN) where the heart rhythm 
originates. Electrocardiograms recordings in freely moving mice show that 
Nfix-null mice (523.10±13.25 bpm, n=4) present tachycardia compared to 
WT mice (466.98±8.42 bpm, n=5). Isolated SAN cardiomyocytes from Nfix-
null mice display a higher intrinsic heart rate (577.80±52.80 bpm, n=7) than 
WT cells (403.80±45.00 bpm, n=7) suggesting that in vivo tachycardia is not 
caused by a dysregulation of autonomic nervous system. Using RNA 
interference, we silenced Nfix gene in neonatal rat ventricular 
cardiomyocytes (NRVCs) and confirmed a +62.2% increase in action 
potential rate in Nfix-silenced (87.60±7.80 bpm, n=20) compared to 
scrambled NRVCs (54.00±9.00 bpm, n=19). It is well established the role of 
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pacemaker currents (funny current and calcium currents) in setting action 
potential rate. We did not find differences in funny current between Nfix-
silenced versus control NRVCs and in Nfix-null versus WT SAN cells, but 
we demonstrated an increase of L-type calcium current in Nfix-silenced 
NRVCs compared with the control. In line with these functional data, we 
found a higher expression of Cacna1d-mRNA in Nfix-null SAN than in WT 
SAN according with a possible increase of CaV1.3 L-type calcium channel 
density. 
In conclusion, our data suggest that NFIX acts as negative modulator of the 
heart rate probably affecting L-type calcium current; however, further 
analysis are necessary to properly clarify the molecular pathway in which 
NFIX acts.  
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Introduction 
1. The transcription factor NFIX. 
NFIX is a transcription factor involved in the development of various organs. 
It belongs to the Nuclear Factor I (NFI) transcription factor family together 
with NFIA, NFIB and NFIC in vertebrates. In mouse, Nfix gene is located 
on chromosome 8 from nucleotide 84699876 to 84800344 and it encodes for 
a protein of ≈48 kDa. NFI proteins bind as a dimer the dyad symmetric 
consensus sequence TTGGC(XXXXX)GCCAA on duplex DNA 
(Gronostajski et al., 2000). Each Nfi-mRNA can be alternatively spliced 
generating multiple proteins that conserve some functional domains (Figure 
1): 
 The N-terminus contains the highly conserved DNA 
binding/dimerization domain (200 amino acids in length). It does not 
show homology in sequence with other known DNA-binding domains 
revealing a unique structure for NFI protein. The N-terminal portion 
is sufficient for the DNA binding and dimerization activity, and it is 
able to activate DNA replication in adenovirus (Mermod et al., 1989, 
Gounari et al., 1990). In particular, it has been shown that the deletion 
or the mutation of four cysteine residues makes the NFI protein non-
functional (Guehmann et al., 1992). 
 The C-terminus contains the domains related to the modulation of 
target genes by NFI proteins. It presents a Proline-rich domain that is 
able to stimulate the transcription of genes in mammalian cells. On the 
other hand, NFI proteins are also able to inhibit mRNA transcription; 
NFI regulatory elements have been identified into silencers regions of 
several transcripts such as peripherin, alpha1B adrenergic receptor and 
GLUT4 genes (Gronostajski et al., 2000).  
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In the mouse, NFI genes are expressed in several tissues (Figure 2A): Nfia 
and Nfib mRNAs are abundant in heart and lung and they are both expressed 
in liver, skeletal muscle and brain. Nfic and Nfix transcripts display a similar 
expression pattern: they are expressed in skeletal muscle at higher levels than 
in heart, liver, kidney, lungs and brain. All Nfi-mRNA have a low expression 
in spleen and testis (Chaudry et al., 1997). During embryonic development 
in mouse, it was shown by in situ hybridization experiments, that Nfia is the 
first transcript detected at day 9 post coitum (9 dpc) in the heart and in the 
septum transversum. At 10.5 dpc, Nfib-mRNA is detected in developing 
lungs, while Nfic in the aortic arches. Only at 11.5 dpc, all Nfi transcripts 
start to be found with an overlapping expression pattern (Figure 2B); Nfi 
genes are highly expressed in brain and in the neural tube. In the liver and in 
skeletal muscle, the main isoform is Nfix. At 12.5-14.5 dpc it is possible to 
find Nfix, Nfia and Nfic in developing skeletal muscles, and Nfix and Nfib in 
the migrating neurons of the spinal cord and cerebellum. In the postnatal 
brain, all the Nfi transcript isoforms are expressed and maintained until 
adulthood (Figure 2C). In particular, Nfix is expressed in the grey matter, the 
hippocampus and in the dentate gyrus (Chaudry et al., 1997).   
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Figure 1. Domains and alternative splicing of NFI genes in vertebrates. From Gronostajski et al., 
2000. 
 
  
Figure 2.  A) NFI transcripts detection in heart, brain, spleen, lung, liver, skeletal muscle, 
kidney and testis in mice. B) Nfi mRNA localization at 11.5 dpc. A= Nfia; B= Nfib; C= 
Nfic; X= Nfix. C) Nfi mRNA localization in the postnatal brain. From Chaudry et al., 
1997. 
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In order to elucidate the role of NFI proteins, several transgenic mouse 
models have been generated: 
 Nfia Knock-out (KO): the majority of mice die at birth (das Neves et 
al., 1999); they show a delayed neuronal development (Piper et al., 
2010) and defects in hydrocephalus (das Neves et al., 1999). 
 Nfib KO mice die at birth (Grunder et al., 2002) and display several 
defects in central nervous system (CNS) (Barry et al., 2008, 
Betancourt et al., 2014) and lung hyperplasia. 
 Nfic KO mice are viable but present defects in tooth development. 
 Nfix KO mice generally die around 3-4 weeks after birth. They 
display defects in sympathetic nervous system (Piper et al., 2011) and 
skeletal muscle development (Messina et al., 2010, Driller et al., 
2007). 
Recently, the role of NFIX in the brain has been elucidated (Campbell et al., 
2008, Driller et al., 2007). During brain development, NFIX is essential in 
neural progenitors commitment (Harris et al., 2016), regulating the specific 
timing of differentiation of neurons and astrocytes. NFIX is able to inhibit 
the expression of the transcription factor Sox9, essential in cortical stem cells 
renewal, resulting in an upregulation of SOX9 in Nfix KO mice (Vidovic et 
al., 2015). Furthermore, NFIX helps the development of the ependymal cells 
in the lateral ventricles through Foxj1 activation (Vidovic et al., 2018). In 
the spinal cord gliogenesis, NFIX participate downstream to the program 
activated by both NFIA and NFIB unrevealing a regulatory network between 
NFI proteins (Matuzelski et al.,  2017). On the other side, recent studies 
demonstrated that NFIX has a pivotal role in the skeletal muscle (Messina et 
al., 2010, Rossi et al., 2016) (Figure 3, A). During skeletal myogenesis, 
PAX7 directly activates the Nfix expression in the transcriptional switch 
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from embryonic to fetal fibers. Specific knock-out of Nfix gene in the skeletal 
muscle obtained from crossing Nfix:loxP+/+ and MyoD:Cre Recombinase 
mice displayed a severe disorganization of muscle fibers in the fetus (Figure 
3, C) but they are indistinguishable from WT at earlier stages of development 
(Messina et al., 2010). Indeed, NFIX is necessary for the simultaneous 
activation of the fetal-specific promoters (such as Mck and β-enolase) and 
the inactivation of embryonic promoters (slow myosin, slowMyHC) in the 
fetus (Figure 3, B). NFIX must associate with MEF2A and PKCθ on Mck 
promoter to activate gene transcription. Furthermore, NFIX represses 
MyHC-I promoter during the fetal myogenesis (Taglietti et al., 2016). In the 
adult mice, the loss of function of NFIX causes a delay in muscle 
regeneration after injury: NFIX indeed silences Myostatin promoter in 
satellite cells, a condition that is necessary for starting the regeneration 
process (Figure 3, D). Recently, Nfix silencing has been proposed as an 
innovative therapeutic strategy to delay the regeneration process in the 
dystrophic muscle to inhibit the pathological process (Rossi et al., 2017). 
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Figure 3.  A) Morphology of WT and skeletal muscle specific Nfix-deficient mouse 
(MyoD:Nfix) at embryonic day 16.5. B) Protein expression of embryonic (slowMyHC) 
and fetal markers (βenolase, MCK) in skeletal muscle Nfix-null and WT. C) Transverse 
section of hind limbs acquired using transmission electron microscopy (TEM) of WT and 
skeletal muscle specific Nfix-deficient mouse at E16.5. D) Schematic illustration of NFIX 
network during fetal myogenesis and in the skeletal muscle in the adult. Modified from 
Messina et al., 2010, Taglietti et al., 2016, Rossi et al., 2016. 
 
Alterations of NFIX gene expression have been reported in human diseases 
such as cancer and overgrowth diseases (Rahman et al., 2017, Liu et al.,2017, 
Kleemann et al., 2018, Malan et al., 2010). Loss-of-function mutations in 
NFIX gene have been associated with two autosomal overgrowth disorders, 
Malan and Marshall-Smith Syndrome; they are rare diseases with an 
incidence of 1/1000000 and appear during childhood (Malan et al., 2010). 
Their phenotype resemble Nfix KO mouse model with anomalies in the 
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skeleton including kyphosis and reduced bone density. This evidence 
supports the use of Nfix KO animals as a suitable model of the pathology 
(Driller et al., 2007). Moreover, NFIX is expressed in the heart (Chaudry et 
al., 1997) and in some Malan Syndrome patients cardiovascular anomalies 
occur in the form of aortic dilatation (Priolo et al., 2018), but its role in 
cardiac physiology has not been elucidated yet.   
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2. Heart development. 
In vertebrates, the heart derives from a group of mesodermal germ layer cells 
that differentiate into mesothelium, endothelium, and myocardium. Despite 
the fact that generally mammals display huge differences in the duration of 
gestation, mice and humans show a very similar sequence of events during 
cardiac development (Figure 4A and B) with minor differences in atrial and 
venous morphology, as demonstrated by Krishnan and colleagues (Figure 
4C).  
At the end of the gastrulation (around day 20 of human or day 8 of mouse 
development), heart development begins with the formation of two 
endocardial tubes (right and left endocardial tubes) which merge to form a 
single tubular structure, also called the “primitive heart tube”. In human, 
around day 20-21 of development, the heart becomes the first functional 
organ in the embryo; it contracts spontaneously pumping the blood through 
the vessels (Moorman et al., 2003). Myocytes start to display a rhythmic 
electrical activity before the fusion of the endocardial tubes. The primitive 
heart tube is then organized into: 
 the “truncus arteriosus” that will divide into aorta and pulmonary 
arteries; 
 the “bulbus cordis” that will generate the right ventricle; 
 the “primitive ventricle” acts as the initial pacemaker even if the 
pacemaker activity is actually made by a group of cells that derive 
from the sinus venous. It will then generate the left ventricle; 
 the “primitive atria” that will generate the atria and their appendages; 
 the “sinus venous”, that is responsible for the blood circulation in the 
early stages of heart development. It will generates the posterior part 
of the right atrium, the sinoatrial node (SAN) and the coronary sinus. 
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Figure 4. Schematic representation of embryonic cardiac developmental stages, growth 
and formation of four-chambered heart in humans (A) and mice (B). In panel C a 
parallelism of cardiovascular development between human and mice. Abbreviations: HF, 
Heart Fields; CM, Cardiogenic Mesoderm; AP, Arterial Pole; OT, Outflow Tract; HT, 
Heart Tube; VP, Venous Pole; RV, Right Ventricle; LV, Left Ventricle; RA, Right Atrium; 
LA, Left Atrium; PA, Pulmonary Artery; A; Aorta. Adapted from “Anatomy & 
Physiology”, 2013 (A) and  Krishnan et al., 2014 (B and C). 
 
The primitive heart tube stretches until it loops and generates the four 
chambers and paired arterial trunks that form the adult heart in a process 
called “cardiac looping” (Moorman e Christoffels, 2003). The tube is 
divided into the cardiac regions along its cranio-caudal axis: the primitive 
ventricle (“primitive left ventricle”) and the trabecular proximal arterial bulb 
(“primitive right ventricle”).  
C) 
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As mentioned before, the sinus venous receives the venous blood from the 
poles of right and left sinus. Each pole receives blood from three major veins: 
the vitelline vein, the umbilical vein and the common cardinal vein. When 
the left common cardinal vein disappears in the tenth week, the right pole 
together with the right atrium generate the wall of the right atrium. The right 
and left venous valves merge and form the septum spurium that will develop 
into the inferior valve of the vena cava and the coronary sinus valve. SAN 
and the atrioventricular node (AVN) pacemaker cells originate from the 
primitive atrium and the sinus venous. Molecularly, SAN precursors are 
characterized by the specific expression pattern of transcription factors 
including TBX18, SHOX2 and ISL-1 (Mommersteeg et al., 2010, Hoogaars 
et al., 2004). NKX2.5 has a complementary expression pathway to TBX2 
and SHOX2 that are required to activate the pacemaker program (Figure 5). 
Indeed, NKX2.5 transcription is blocked in SAN by SHOX2 but not in the 
myocardium chambers where it activates, together with TBX5, the 
myocardium promoters of Nppa, Cx40 and Cx43 genes (Hoogaars et al., 
2007). The sinus venous is a symmetric structure but SAN originates only in 
the right atrium because of the presence of the transcription factor PITX2c 
that specifically suppresses the SAN program in the left region allowing the 
correct asymmetric development (Mommersteeg et al., 2007; Barbuti and 
Robinson 2015).  
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Figure 5.  Schematic representation in sinus node specification.  
Modified from Barbuti and Robinson., 2015. 
 
In the majority of the mammals, during cardiac development the heart rate is 
higher than in adulthood. In the first month of human development, 
embryonic heart rate (EHR) accelerates linearly peaking at 165-185 bpm in 
humans. During the 15th week, EHR decelerates to 150 bpm and then 
deceleration rate slows reaching an average rate of 145 bpm (Figure 6). 
 
 
Figure 6.  Double logarithmic plot of heart rate (beats min-1) as function of body weight 
in the fetal (filled symbols) and postnatal life (open symbols). Data are from Altman & 
Dittmer (1964). 
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3. The Heart. 
The heart is a muscular organ and it works as a mechanical pump pushing 
the blood through the vessels in order to diffuse the oxygen and nutrients in 
the whole body. In mammals, the heart is organized into four chambers: right 
and left atria, right and left ventricles. Due to the presence of atrioventricular 
valves (tricuspid and mitral –bicuspid-), the circulation is allowed only from 
the atria to the ventricles avoiding the blood reflux to the lungs. To 
synchronize the process, the blood pumping is set with a precise contraction 
sequence. For this reason, in the heart it is possible to classify muscle cells 
into working myocardium or conduction system.  
 
I. The Working Myocardium. 
In the working myocardium, cardiomyocytes build the atria and the 
ventricles and through their contraction generate the tension necessary to 
circulate the blood. Every cardiomyocyte is electrically coupled to the next 
through low-resistant gap junctions (connexins) so that the heart can be 
considered as a functional syncytium.   
 
II. The Conduction System 
While in the skeletal muscle, the electrical impulse that trigger the 
contraction origins in the nervous system, in the heart the signal, in the form 
of spontaneous and repetitive action potentials, is generated from specialized 
cells of the conduction system. . These cells represent the pacemaker regions 
of the heart.  Due to their role, these pacemaker cells have rudimentary 
contractile filaments and indeed, they contract relatively weakly if compared 
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with cells of the working myocardium. Sinoatrial cells, for example, are 
generally smaller, do not show striations and have a peculiar spindle shape. 
(DiFrancesco et al., 1986) 
In the heart, there are several pacemakers (see Figure 7A):  
 the sinoatrial node (SAN) 
 the atrioventricular node (AVN) 
 His bundle (His) 
Physiologically, the main pacemaker of the heart is the sinoatrial node (sinus 
node, SAN) located in the wall of the right atrium near the entrance of 
superior vena cava. SAN cardiomyocytes form the “natural pacemaker” of 
the heart”. The reason why SAN acts as the main pacemaker region is that 
SAN cells, due to a unique combination of ion currents (Figure 7B), generate 
action potentials with a higher rate than the other pacemaker regions in 
phenomena called “overdrive suppression”.  The functional architecture of 
the SAN tissue includes a central part near the sinoatrial artery (“primary 
pacemaker cells”) surrounded by peripheral cells (“secondary pacemaker 
cells”). Both primary and secondary pacemaker cells spontaneously fire, but 
in physiological conditions, only the primary pacemaker cells generate the 
electrical impulse (Dobrzynski et al., 2013). Secondary pacemaker cells have 
different roles: 
1. protecting the primary pacemaker cells from the influence of atrial 
cardiomyocytes; 
2. helping the correct propagation of the electrical stimulus; 
3. becoming the leading pacemaker when some problems occur in the 
SAN (Dobrzynski et al., 2013).  
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The electrical impulse originated by the SAN travels rapidly across the atria 
and then, slows down in the AVN in order to let the atria contraction to finish 
before ventricles start to contract. AVN works as a “back-up” pacemaker in 
case of SAN failure. At this point, the stimulus reaches the His bundle that 
depart from the AVN and then it rapidly spreads through Purkinje fibers in 
the ventricles.  
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Figure 7.  A) Schematic representation of the cardiac conduction system. Sinus node 
(SAN), Atrioventricular Node (AVN), His Bundle (His), Purkinjie Fibers (PF), Atrial 
Myocardium (AM), Ventricular Myocardium (VM). From Cingolani et al., 2018. B) 
Mouse SAN tissue limited by crista terminalis (CT) and by the superior and inferior cavae 
veins (SVC, IVC) which are cut along their major axis. (RA) and (LA) indicate the right 
and left atrium, respectively, separated by the interatrial septum (IAS). On the bottom, 
representative traces of ion currents recorded in SAN cells. From Mangoni et al., 2006. 
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The autonomic nervous system physiologically participates to the activity of 
the heart because of the presence of sympathetic (SNS) and parasympathetic 
(PSNS) branches in cardiac tissue. Release of catecholamines that bind to β-
receptors in cardiac tissues cause an increase of: - the contraction force of 
the fiber (positive inotropy); - the AVN conduction velocity (positive 
dromotropy); - the heart rate (positive chronotropy); - the electrical 
excitability (positive bathmotropy). Instead, PSNS has opposite effects in the 
heart due to the release of acetylcholine that bind to the muscarinic receptors 
in the heart. 
In humans, PSNS influences the heart physiology more than the SNS 
resulting in a resting adult heart rate in a range between 60 and 100 bpm. 
Anomalies of the heart rate (arrhythmias) can result in bradycardia (<60 
bpm at rest) or tachycardia (>100 bpm at rest). There are four main types of 
cardiac arrhythmias: 
 Premature heart beats (extra beats): the most common arrhythmia. 
Premature atrial, ventricular or junctional contractions happen during 
life and they can be associated with stress, caffeine or smoking. They 
generally do not need any pharmacological treatment or have long-
term complications.   
 Supraventricular tachycardia (SVT): is a fast heart rate condition that 
originates in the upper part of heart due to the presence of re-entry 
circuits or an increased cardiac automaticity. It includes atrial 
fibrillation, paroxysmal supraventricular tachycardia, atrial flutter and 
the Wolff-Parkinson-White syndrome. 
 Ventricular arrhythmias: occur in the lower part of the heart. They 
include ventricular tachycardia (in which the SAN loses the control of 
heart rate and the electrical stimulus originates in secondary 
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pacemakers) and ventricular fibrillation (several impulses originates 
from different areas resulting in a not-controlled fast heartbeat that 
does not allow a proper blood circulation).  
 Bradyarrhythmias: is a slow heart rate that can be related to: - a 
structural adaptation (as the hypertrophic heart of an athlete); - a 
change in vagal tone; - a dysfunction in the SAN (Sick Sinus 
Syndrome); - anomalies in the conduction system efficiency. 
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4. The Cardiac Action Potential. 
Action potential is a fast change in cellular membrane potential that is caused 
by an exchange of ions across the cellular membrane. Cardiomyocytes are 
electrically excitable cells and they can produce different action potentials 
(APs) due to a differential expression of ion channels on the cellular 
membrane. It is possible to distinguish five different phases in a typical 
model of ventricular AP (Fig. 8): 
 Phase 0: consists in a fast depolarization of the membrane potential 
from -90 mV (resting membrane potential, RMP) to +50 mV due to 
the activation of sodium channels (INa). Sodium channels activate 
when the electrical stimulus causes the depolarization of the RMP to 
≈-65 mV (threshold value). Only if the threshold is reached, the action 
potential can originate. AP is a “all or none” phenomenon. In SAN 
cells, the opening of L-type (“long lasting”) calcium channels (ICaL) 
causes the depolarization during the phase 0. These channels activate 
slower than sodium channels as demonstrated by a reduced value of 
the slope that represents the maximum rate of voltage change 
(dV/dTmax). Moreover, phase 0 lasts less than 2ms in ventricular 
myocytes while it is slower in SAN cells (10/20 ms). 
 Phase 1: after the AP reaches the depolarization peak in phase 0, there 
is a transient  repolarization of the membrane potential due to a 
simultaneous inactivation of sodium channels and activation of the 
“transient outward”  potassium current (Ito). Physiologically, the 
inactivation of sodium channels guarantees the absolute refractory 
period in which the cardiomyocytes cannot produce a new action 
potential. Indeed, sodium channels recover from inactivation when the 
membrane hyperpolarizes and then, they move on the closed 
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conformation. It is not possible to pass directly from the inactivated to 
the open conformation; the channels must close before re-activating 
and ensuring the refractoriness. During phase 1, the membrane 
potential does not complete the repolarization to RMP due to the rapid 
inactivation of Ito potassium channels.  
 Phase 2: also referred as the “plateau phase” in which an electrical 
balance between inward calcium (ICaT and ICaL) currents and outward 
potassium currents (delayed rectifier potassium channels) is 
established. During phase 2, calcium ions enter inside the cell and bind 
the ryanodine receptors (RYR) on the sarcoplasmic reticulum (SR) 
allowing the calcium flow in the cytosol (“Calcium-induced calcium 
release”) a mechanism known as excitation-contraction coupling. 
Considering that contraction in the working myocardium is 
fundamental, it is understandable the reason why SANCs completely 
lacks this phase. 
 Phase 3: consists in the rapid repolarization of the AP. In this phase, 
L-type calcium channels inactivate, while slow delayed rectifier (IKs) 
potassium channels (activated during phase 2) remain open allowing 
a net outward positive current. During the repolarization, other 
potassium channels open: rapid delayed rectifier (IKr) and inwardly 
rectifying (IK1) channels. IKr channels close in proximity of RMP while 
IK1 remains active throughout the phase 4 setting the RMP. In the 
SAN, phase 3 depends on the inactivation of L-type calcium channels 
and the opening of IKr channels. During phase 3, there is the “relative 
refractory period”, in which due to the more hyperpolarized potential, 
sodium channels partially recover from the inactivation passing to the 
closed conformation. In this period, it is possible to evoke a new AP 
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only with a stronger stimulus that allows the complete activation of 
sodium channels. 
 Phase 4: in non-pacemaker cells, it occurs when the cell reaches the 
resting potential around -90mV (diastole phase). Ion concentration is 
continuously restored by the activity of ion pumps that guarantee the 
physiological ion concentrations inside and outside the cell. 
Physiologically RMP results from IK1. In the pacemaker cells, there is 
not a RMP; when the cell reaches -70 mV, a slow depolarization 
occurs (diastolic depolarization) due to the activation of HCN 
channels (If current). During the second part of the diastolic 
depolarization, T-type (“Transient”) calcium channels activate 
causing the crossing the threshold to evoke a new AP. 
 
 
Figure 8.  Schematic representation of Action Potentials in different regions of the heart. 
On the bottom, a schematic representation of a human ECG to show the correlation 
between action potentials and cardiac cycle. Adapted from Hume et al., 2012  
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5. HCN Channels. 
Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) channel family 
consist of four isoforms: HCN1, HCN2, HCN3 and HCN4. HCN1, HCN2 
and HCN4 have been reported in both heart and brain tissues, while HCN3 
seems to be confined in neurons (Moosmang et al., 2001). HCN4 is the main 
isoform expressed in the SAN in all species tested (human, mouse, rabbit) 
(Chandler et al., 2009, Brioschi et al., 2009). While HCN2 is the most 
abundant isoform in ventricles, HCN1 is also expressed in the SAN and the 
atria (Herrmann et al., 2011). Based on the homology in sequence, HCN 
channels can be considered as members of the voltage-gated potassium Kv 
channels superfamily and of CNG cyclic nucleotide-gated channels (Ulens e 
Siegelbaum, 2003, Santoro et al., 1997). These channels work as a tetramer 
in which each subunit is composed of six different transmembrane helical 
domains (S1-S6). (Zagotta et al., 2003). The core of HCN channels is well 
conserved (>80%) among the isoforms while N-terminus and C-terminus are 
more divergent. Structurally, HCN channels have: 
1. a voltage sensor localized in the positively charged S4 domain; 
2. the GYG pore (between S5 and S6) sequence typical of potassium 
channels; 
3. the CNBD domain that is able to bind cyclic nucleotides in the C-
terminus (Baruscotti et al., 2005) (see Figure 9).  
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Figure 9. Structural representation of HCN channel subunit. From Biel et al.,2002. 
As mentioned before, HCN channels are the molecular components for a 
hyperpolarization-activated current (“funny current”, If) that sustains the 
slow diastolic depolarization in pacemaker cells. A similar current, Ih, has 
also been described in neurons where it contributes to the AP firing, 
excitability and modulation of synaptic activity (Pape et al., 1996, Robinson 
et al., 2003). If has a “funny” behaviour: it activates upon membrane 
hyperpolarization, it is activated both by voltage and cyclic nucleotides 
(Figure 10A). The activation gate of HCN channels is closed when the S4 is 
in its outermost configuration at positive voltages but open in other channels. 
This “inverted” gating model is supported by a recent study indicating that 
the S4–S5 linker of HCN channels couples the movement of the voltage-
sensing S4 helix to the opening and closing of the gate as previously 
proposed for depolarization-activated potassium channels (Chen et al. 2001).  
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The primary sequence of the pore contains the same glycine-tyrosine-glycine 
(GYG) motif of highly selective K+ channels. Curiously, HCN channels are 
not selective for K+ ions but they allow other monovalent ions to permeate 
including Na+ and K+ with a relative permeability ratio PNa+/PK+ of 0.20 
(Gauss et al. 1998, Ludwig et al. 1998, Santoro et al. 1998). Under 
physiological conditions HCN channels mediate an inward Na+ current and 
not a K+ current. In tetrameric K+ channels, four copies of GYG motifs 
provide the selectivity filter for K+ ions (Lu et al. 2001, Zhou et al. 2001). 
The presence of a single GYG sequence in HCN channels indicates that one 
copy of this motif is not sufficient to confer selectivity for K+ ions. This 
could be explained by a different spatial configuration of the channel due to 
a change in the protein folding.  
When overexpressed in heterologous systems, all the HCN isoforms either 
alone or in combination failed to reproduce completely the native If 
suggesting that cellular environment is essential to modulate its properties 
(Altomare et al., 2003, Qu et al., 2002). From its first discovery in rabbit 
SANCs in late 1970s (Brown et al., 1979), If current was found not only in 
the primary pacemaker of other species, like human (Verkerk et al., 2007) 
and mouse (Mangoni et al., 2001) but also in several regions of the 
conduction system including the AVN (Choisy et al., 2015) and Purkinjie 
fibers (DiFrancesco, 1981). However, its detection seems to be restricted not 
only in pacemaker cardiomyocytes and in embryonic/new born ventricular 
myocytes (Robinson et al., 1997, Wang et al., 2013) where they contribute 
to the generation of action potentials (Figure 10B).  Recent studies have 
demonstrated that f-channels are also present in non-pacemaker 
cardiomyocytes, and become upregulated in cardiac hypertrophy and failure 
where they may contribute to the generation of an arrhythmogenic substrate 
(Cerbai & Mugelli, 2006). 
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Figure 10. A) If current traces recorded in SAN myocyte during steps to the voltages as 
indicated. On the right, the effect of adrenergic (Iso) and muscarinic (ACh) stimulation 
on the activation curve of If. Adapted from Baruscotti et al., 2004. B) Comparison of If 
current and the generation of action potentials between SAN and Purkinje cells. Adapted 
from Barbuti et al., 2007. 
 
The If is not the only current sustaining the diastolic depolarization since  it 
has been demonstrated that spontaneous beating activity does not stop in 
presence of caesium, an If blocker (Denyer et al.,1990). On the other hand, 
Ivabradine (Servier) inhibits selectively HCN channels causing a reduction 
of heart rate without side effects. Ivabradine causes the slowing of the firing 
rate of SAN myocytes reducing the slope of the diastolic depolarization 
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phase (Bucchi et al., 2006) suggesting a central role of this current in setting 
cardiac rate. Spontaneously beating mouse SAN cells that show an intrinsic 
fast action potential rate due to a high in vivo heart rate, display a greater If 
current density (Baruscotti et al., 2011). Furthermore, a transgenic mouse 
model with an inducible-cardiac specific Hcn4 KO causes in vivo deep 
bradycardia suggesting a correlation between HCN channels and heart rate 
(Baruscotti et al., 2011). 
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6. L-type Calcium Channels. 
The L-type Calcium channels (LTCCs) belongs to the voltage-dependent 
calcium channels (VDCCs) family together with T-, P-, N- and R-type 
calcium channels. “L” stands for “long lasting” referring to their relatively 
long duration of activation. Structurally, they have a pore-forming subunit 
(α1) that is organized into four homologous domains (I-IV). Each domain 
consists of the six α-helical transmembrane domains that present:  
1. the voltage sensor localized in S4 region;  
2. a  P-loop constituting  selectivity filter of; 
3. the channel pore resulting from S6 segments association (Figure 11) 
(Striessnig et al., 1999). 
 
 
Figure 11. Schematic representation of α1 subunit. 
 
α1 subunit associates with auxiliary subunits (β, α2δ and γ) and calmodulin 
to assemble the fully functional channel. Based on the different α1 subunits, 
LTCCs are indicated as CAV1.1, CAV1.2, CAV1.3 or CAV1.4 (as shown 
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in Table 1) and they are all sensitive to dihydropyridines (DHPs) with 
differences in affinity. 
 
α1 GENE NAME PROTEIN NAME 
Cacna1s CAV1.1 
Cacna1c CAV1.2 
Cacna1d CAV1.3 
Cacna1f CAV1.4 
Table 1. Gene names encoding for L-type calcium channels. 
 
LTCCs are expressed throughout the body with a specific organization in the 
tissues. CAV1.1 is the main isoform of the skeletal muscle where it mediates 
the excitation-contraction (EC) coupling (Tanabe et al., 1988); CAV1.4 is 
mainly expressed in the immunity system (Kotturi et al., 2003), spinal cord 
and retina (McRory et al., 2004). CAV1.2 and CAV1.3 are present in the 
brain, endocrine cells and in the heart (Catteral et al.,  2000). In the endocrine 
cells, LTCCs mediate both the aldosterone secretion in the adrenal cortex 
(Barrett et al., 2016) and the endocytosis of catecholamines from chromaffin 
cells (Rosa et al., 2012).  In the heart, CAV1.2 is the most abundant LTCC 
isoform and it is essential in the EC coupling in the working myocardium. 
CAV1.2 is generally considered the main determinant of ICaL in the heart. 
Indeed, CAV1.3 was thought to be present specifically in neurons (Hell et 
al., 1993), only recently it has been demonstrated that is present in the atria 
and in the SAN (Mangoni et al., 2003). CAV1.3 show less sensitivity for 
DHPs (Xu et al., 2001), a lower voltage threshold for activation (-50 mV) 
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(see Figure 12) and slower inactivation kinetics than CAV1.2 channels 
(Koschak et al., 2001).  
 
 
Figure 12. Representative traces and current-voltage curves of the mean current 
density of total CAV1.2+CAV1.3 current, CAV1.2 current and  CAV1.3 current in murine 
sinoatrial cells. Adapted from Christel et al., 2012. 
 
In addition to the “membrane clock” model of pacemaker activity in the heart 
which considers If  as the starter of the diastolic depolarization, the “calcium 
clock” model indicates that spontaneous rhythmic Ca2+ release from the SR 
activates the Na+/Ca2+ exchanger (NCX) mediating a net inward current that 
is able to depolarize the membrane voltage to the threshold (Bogdanov et al., 
2001). Recently, this model has been updated into the “coupled-clock” 
model, adding the membrane calcium channels involvement to generate the 
pacemaker activity (Lakatta et al., 2010). Indeed, Ca2+ channels can be found 
in isolated rabbit SAN cells where they can influence the cellular beating rate 
(Hagiwara et al., 1988). Moreover, the administration of Nifedipine (a 
specific LTCC blocker) blocks the automaticity in the centre of rabbit SAN 
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but not in its periphery (Kodama et al., 1997).  CAV1.2 and CAV1.3 are both 
involved in the pacemaker activity, with an emerging role of CAV1.3 into 
the diastolic depolarization phase (Mangoni et al., 2003). Indeed, the 
evidence that CAV1.3 activates more rapidly and at more negative 
potentials, suggests that CAV1.3 to contribute more significantly than 
CAV1.2 to the slow diastolic depolarization phase. To dissect CAV1.2 and 
CAV1.3 contributions to the SAN automaticity, a transgenic mouse model 
in which CAV1.2 is insensitive to DHPs was generated (Sinnegger-Brauns 
et al., 2004, Christel et al., 2012). Christel and colleagues demonstrated not 
only a major contribution of CAV1.3 to the diastolic depolarization but also 
the evidence that only CAV1.3 channels are strongly co-localized with 
RYR2 in the SAN cells. This co-localization facilitates the RYR-mediated 
calcium release during the late diastolic depolarization. As shown in figure 
13, the transgenic mouse model of Cacna1d KO (CAV1.3-/-) displays 
bradycardia associated with sinoatrial arrhythmia (Platzer et al., 2000). This 
phenotype is independent by the system nervous system as demonstrated by 
the evidence that isolated CAV1.3-/- SAN cells show a lower and irregular 
action potentials firing rate in vitro when compared with WT cells (Mangoni 
et al., 2003). 
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Figure 13. A) ECGs recorded from freely moving WT and CAV1.3-/- mice. B) Recorded 
spontaneous action potentials from WT and CAV1.3-/- SAN cells. On the bottom, analysis 
of AP interval between WT and CAV1.3-/- cells. From Mangoni et al., 2006. 
 
LTCCs can be also modulated by the activity of the autonomic nervous 
system in both a positive and negative way. β-adrenergic stimulation leads 
to the production of cyclic-adenosine-monophosphate (cAMP) that is 
necessary to activate PKA. While it has been demonstrated that cAMP can 
directly activate f-channels binding their CNBD domain (DiFrancesco et al., 
1991), the PKA-dependent phosphorylation increase LTCC conductance 
(Mangoni et al., 2003).  
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Aim  
The transcription factor NFIX is expressed in several tissues and it is 
important both during development and in adulthood. It has a pivotal role in 
the skeletal muscle modulating not only transcriptional switch from 
embryonic to fetal myogenesis but also the regeneration process in the adult 
mice (Messina et al., 2010, Rossi et al., 2016). Until now, the expression 
profile and the role of NFIX in the heart has never been studied. Since 
skeletal and cardiac muscle share several physiological properties, the aim 
of my PhD thesis was to investigate for the first time the role of this 
transcription factor in heart function. To reach this purpose I will perform in 
vivo experiments in Nfix-deficient mice and age-matched WT controls to 
investigate the phenotype of NFIX loss-of-function. I will also use RNA 
interference to downregulate Nfix-transcript in an in vitro model of rat 
neonatal cardiomyocytes to perform electrophysiological experiments. 
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Materials and methods 
1. Statistical Analysis 
All the data are displayed as Mean Value ± Standard Error of the Mean. 
Either Student’s T-test or One-Way ANOVA (followed by Fisher’s Low 
Standard Deviation post-hoc test ) were used to determine if there are 
differences between two (T-test) or more (ANOVA) independent data sets 
(*p≤0.05). Shapiro-Wilk normality test was performed on each data set and 
at the 0.05 level, they confirmed a normal distributed population. 
 
2. Mouse model 
This project has been developed in collaboration with the group of prof. 
Graziella Messina who gave us the possibility to use Nfix-null mice (C57 
BL6/1295) and wild type (WT) littermates or age-matched mice as controls. 
Nfix-null mice were generated crossing heterozygous Nfix-null+/- mice 
obtained from Prof. Richard M. Gronostajski of University of Buffalo. Due 
to the severe phenotype of Nfix-null, from postnatal day 21, the food was 
supplemented with a soft dough chow (Transgenic Dough Diet, Bioserv), as 
previously described (Campbell et al., 2008). All the procedures were 
conformed to Italian law (D. Lgs n° 2014/26, implementation of the 
2010/63/UE) and approved by the Università degli Studi di Milano and its 
Animal Welfare Body (OPBA) and the Italian Minister of Health 
(n.273/2018-PR).  
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3. RNA Extraction and Retrotranscription 
To isolate RNA from tissues, RNAse-free glass mortar tubes, pestles, and 
sterile insulin needles were used to homogenize the sample in 1 mL of 
TRIzol® Reagent (Thermo Fisher). After the mechanical disruption of cell 
membrane, the sample was centrifuged at 12’000 g x 5 minutes and the 
supernatant was transferred in a new RNAse-free tube. At this point, 200 µL 
of Chloroform:Isoamyl alcohol 49:1 (Sigma Aldrich) was added to the 
mixture, inverted and then incubate for 4 minutes at room temperature. The 
sample was centrifuged at 12’000 g x 15 minutes at 4-10°C. After the 
centrifuge, it is possible to recognize three different density phases in the 
sample: 
- An aqueous phase containing RNA; 
- An intermediate phase; 
- An organic phase containing DNA and proteins. 
Only the aqueous phase is transferred in a new RNAse-free tube in which 1 
µL of 20 µg/mL Glycogen (Thermo Fisher) and 400 µL of Isopropanol 
(Sigma Aldrich) were added and gently inverted ten times. To facilitate RNA 
precipitation, the sample was incubated for 10 minutes at room temperature 
and then centrifuged at 12’000 g x 10 min at 4-10°C. RNA pellet was washed 
for three times in 1 mL of cold 75% Ethanol (Sigma Aldrich) and centrifuged 
at 7’500 g x 5 min at 4-10°C. After discarding the supernatant and the 
complete evaporation of ethanol from the tube, the pellet was risuspended in 
MilliQ Water (Millipore-Sigma Aldrich) and incubated for 10 minutes at 
60°C. Fresh isolated RNA was then stored at 80°C. RNA was quantified 
using Ultrospec® 500/1100 pro spectrophotometer (Amersham Biosciences) 
and proteins and phenols contamination were evaluated using 
ABS260nm/ABS280nm and ABS260nm/ABS230nm values. To eliminate residual 
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genomic DNA, 1 μg of total RNA from each sample was treated with DNAse 
I RNAse-Free (Thermo Scientific) using the mixture in Table 1 and incubated 
for 30 minutes at 37°C. To block DNAse I activity, 1 µL of 50mM EDTA 
was added to the mixture and then incubate it for 10 minutes at 65°C. cDNA 
retrotranscription with random examers of DNAse-treated RNA was 
performed using Thermo Fisher’s Kit “cDNA Synthesis Kit for RT-qPCR" 
(Table 2) following different temperature steps: 25°C for 10 minutes, 50°C 
for 15 minutes and 85°C for 5 minutes. 
 Quantity 
RNA 1 µg 
DNAse I 1U/µL 1 µL 
Buffer MgCl2 10X  1 µL 
Milli-Q® Water Up to the volume 
Final Volume 10 µL 
Table 1 DNAse I mixture. 
 Quantity 
DNAse-treated RNA 1 µg 
Buffer Reaction Mix 5X 4 µL 
Maxime Enzyme Mix 10X 2 µL 
Milli-Q® Water Up to the volume 
Final Volume 20 µL 
Table 2 Retrotranscription mixture. 
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4. qPCR and RNA sequencing 
Gene expression was quantified by real-time qPCR (Line-gene 9600plus, 
Bioer); experiments were carried out using Maxima SYBR Green/ROX qPCR 
Master Mix (Thermo Scientific) as shown in Tables 3 and 4. qPCR conditions 
were: first step at 95°C for 5 minutes followed by 45 cycles at 95°C for 15 
seconds, 60°C for 30 seconds and 72°C for 30 seconds. The melting curve 
analysis (60°C to 96°C) was performed at the end of the protocol to verify 
the presence of a single amplicon. Each sample was run in triplicate and the 
mean cycle threshold (Ct) of the gene of interest (GOI) was normalized to 
the mean Ct of the housekeeping (HSK) gene (Gapdh or Rps15a). The data 
are displayed as 2-ΔCt*100±SEM, considering ΔCt=CtGOI-CtHSK. The data are 
displayed as 2-ΔCt*100±SEM, considering ΔCt=CtGOI-CtHSK. Because of the 
large range of values among the populations, statistical analysis was 
performed with the logarithm 2-ΔCt*100 as used in literature (Scavone et al., 
2013). 
 
 Quantity 
cDNA 10 ng 
Forward Primer 10 μM* 1.25 μL 
Reverse Primer 10 μM* 1.25 μL 
SYBR® 2X 12.5 μL 
Milli-Q® Water Up to the volume 
Final Volume 25 μL 
Table 3 Real-time qPCR mixture. 
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GENE 
NAME 
FORWARD PRIMER 5’3’ REVERSE PRIMER 5’3’ 
Mus 
musculus  
Nfix 
CTGGCTTACTTTGTCCACACT CCAGCTCTGTCACATTCCAGA 
Mus 
musculus 
Gapdh 
AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 
Mus 
musculus 
Rps15a 
AAACTGACGTGAAGGGAGCA CCTCACAGGAAGGTTGAACAAG 
Mus 
musculus 
Nkx2.5 
GACGTAGCCTGGTGTCTCG GTGTGGAATCCGTCGAAAGT 
Mus 
musculus 
Myh6 
TGCTCAGAGCTCAAGAAGGAT CCCAGCCATCTCCTCTGTTA 
Mus 
musculus 
Myh7 
CAGCAGACTCTGGAGGCTCTT AGGGCGACCTCAACGAGAT 
Mus 
musculus 
Mlc2v 
GGACACATTTGCTGCCCTA ATCGTGAGGAACACGGTGA 
Mus 
musculus 
Cacna1c 
TAGTGTCCGGAGTCCCAAGT GAAGAGCACAAGAAGGGCAAT 
Mus 
musculus 
Cacna1d 
GTTGTAAGTGCGGTAGAAAGCA CTGGTGCCTCTTGCATAGTTT 
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Table 4 Primers sequences. All primer pairs were tested for an efficiency >95%. 
  
Mus 
musculus 
Cacna1g 
TAACCTGCTTGTCGCCATT ACTCGTATCTTCCCGTTTGC 
Mus 
musculus 
Cacna1h 
CCTGCTGGACACTGTGGTT GGAGCATGAAAAGAAGACCAA 
Rattus 
norvegicus 
Nfix 
CTGGCTTACTTTGTCCACACT CCAGCTCTGTCACGTTCCAGAC 
Rattus 
norvegicus 
Gapdh 
GATTTGGCCGTATCGGAC GAAGACGCCAGTAGACTC 
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5. Histological Analysis 
Hearts were blocked in diastole using 100 nM CdCl2 (Sigma Aldrich) and 
immediately fixed in 4% PFA (Sigma Aldrich). Excess of fixative was 
removed with two washes with PBS (Sigma Aldrich) of 5 minutes each under 
gentle shaking. Samples were successively re-equilibrated in PBS-sucrose 
solutions at increasing sucrose concentrations: 1h with 7,5% sucrose, 1h with 
15% sucrose, and O/N in 30% sucrose, at 4°C under constant shaking. The 
day after, samples were embedded in OCT (Bio-Optica), included in 
nitrogen-cooled isopentane (VWR), and maintained at -80°C until further 
processing. For Hematoxilin and Eosin and Milligan’s Trichrome stainings, 
7μm sections were cut with a cryostat (Leica) on positively charged glass 
slides (Superfrost Plus, Thermo Scientific). Muscle sections were stained 
with hematoxylin and eosin (Sigma Aldrich) according to standard protocols. 
Briefly, samples were washed in distilled water and stained with 
hematoxylin for 4 minutes. Excess of staining was removed with a 15 
minutes wash under running water, then slices were progressively 
dehydrated to 90% Ethanol (VWR) and stained for 7 minutes with 0,5% 
Eosin in 90% Ethanol. Slices were then further dehydrated through 
successive steps in graded alcohol solutions, cleared with xylene (VWR) and 
mounted with Eukitt mounting medium (Bio-Optica). For Milligan’s 
trichrome, sections were fixed for 1 hour with Bouin’s fixative (Sigma 
Aldrich) and rinsed for 1 hour under running water. Sections were then 
rapidly dehydrated to 95% Ethanol in graded ethanol solutions; successively 
they were passed in 3% potassium dichromate (Sigma Aldrich) for 5 minutes 
and rapidly washed in distilled water. Then, they were stained with 0,1% 
acid fuchsin (Sigma Aldrich) for 30 seconds, washed again in distilled water 
and passed in 1% phosphomolybdic acid (Sigma Aldrich) for 3 minutes. 
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After, they were stained with Orange G (2% in 1% phosphomolybdic acid) 
(Sigma Aldrich) for 5 minutes, rinsed in distilled water, passed in 1% acetic 
acid (VWR) for 2 minutes, stained with 1% Fast Green for 5min (Sigma-
Aldrich), passed in 1% acetic acid for 3 minutes, rapidly dehydrated to 100% 
Ethanol and cleared in Xylene before mounting with Eukitt (Bio-Optica). 
Images were acquired with a Leica-DMI6000B microscope equipped with a 
10X magnification objective. Leica DFC400 camera was used for image 
capture. 
 
6. In vivo Telemetry 
6 month-old male mice were implanted with a radio frequency transmitter 
(TA10ETA-F20, DSI) as previously described (Baruscotti et al., 2011). The 
radio-transmitter allowed the simultaneous recordings of cardiac rate, 
activity and temperature in freely moving conditions. To allow the complete 
recovery from the surgery, recordings started 15 days after the surgery. 
ECGs were collected during both night and day for 5 days giving a 2 minutes 
recording every 30 minutes. Data were acquired and analyzed with the 
Dataquest 4.2 software (DSI).. 
  
46 
 
7. Isolation of Sinoatrial Node Cells (SANCs) 
SANCs were isolated from 6-month old Nfix-null and WT mice (both males 
and females). Hearts were explanted and put immediately in Tyrode’s 
solution (mM: 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 5.5 D-glucose, 5 
Hepes-NaOH; pH 7.4) plus 1000 U Eparin.  During the sinus node (SAN) 
dissection, the tissue is maintained in warm Tyrode and placed onto the stage 
of a stereoscopic microscope. Once the tissue is dissected, it is cut in 4-5 
pieces and immediately washed for three times in a low-calcium solution 
(mM: NaCl 140, KCl 5.4, MgCl2 0.5, KH2PO4 1.2, HEPES-NaOH 5, Taurine 
50, D-Glucose 5.5; pH=6.9) for 1 minute. Then, SAN is enzymatically 
digested for at least 25 minutes at 37°C using low-calcium solution plus 0.2 
mM CaCl2, 1 mg/mL BSA, 0.45 U/mL Protease (Sigma Aldrich), 1.30 U/mL 
Elastase (Sigma Aldrich) and  250 U/mL Collagenase IV  (Worthington). 
Once the enzymatic incubation is over, SAN is washed three times in zero-
calcium solution (mM: KOH 80, L-Glutamic Acid 70, KCl 20, βOH-Butyric 
Acid 10, KH2PO4 10, HEPES-KOH 10, Taurine 10, EGTA-KOH 1; 1 
mg/mL BSA, pH=7.4) and then mechanically digested for 10 minutes in 3 
mL of zero-calcium solution.  Then, cells are gradually adapted to 
physiological calcium concentrations using the following steps every 4 
minutes a 4°C: 
1) + 72 µL of a solution containing 10mM NaCl and 1.8 CaCl2; 
2) + 153.6 µL of a solution containing 10mM NaCl and 1.8 CaCl2; 
3) + 374.4 µL of Tyrode plus 1 mg/mL BSA; 
4) + 1200 µL of Tyrode plus 1 mg/mL BSA; 
5) + 4200 µL of Tyrode plus 1 mg/mL BSA; 
At the end of the protocol, SANCs were plated in the center of 35mm-Petri 
dishes and maintained at 4°C for the day of the experiment. 
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8. Isolation and Infection of neonatal rat ventricular 
cardiomyocytes (NRVCs) 
Primary cultures of NRVCs were prepared as previously described (Scavone 
et al., 2013). After 24 hours from NRVCs isolation, 4 µg/mL Polybrene was 
added to four different plates with 106 NRVCs. Two plates were infected 
with a lentivirus carrying the vector plKO.1 with either a scrambled hairpin 
sequence (Scramble) or short hairpin RNA specific for downregulating Nfix-
mRNA (Nfix-sh) and puromycin resistance cassette (Figure 1) with a final 
multiplicity of infection (MOI) of 50. 
 
Figure 1. pLKO.1 vector. 
After 24 hours from the infection, cells were washed twice in PBS (Sigma 
Aldrich) and Polybrene was removed from all the four plates with NRVCs. 
Three plates (not infected, Scramble and Nfix-sh) were put in stringent 2 
µg/mL puromicine selection. After 2 days in puromicine, non-infected 
NRVCs died, and only the infected cells survived. To evaluate the efficiency 
of Nfix downregulation for each experiment, we compared Nfix expression 
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level between Not infected NRVCs (that we treated with Polybrene but not 
with puromicine), Scramble and Nfix-sh NRVCs. Two days before single 
cell electrophysiological recordings, infected NRVCs were dissociated into 
single cells after incubation for 2-3 minutes with Trypsin-EDTA (Sigma 
Aldrich) a 37°C and centrifuge 300 g for 5 minutes. 
 
9. Electrophysiology 
For electrophysiology, cells were placed onto the stage of an inverted 
microscope and superfused with Tyrode solution containing (mM): 140 
NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 5.5 D-glucose, 5 Hepes-NaOH; pH 7.4. 
Patch-clamp pipettes had resistances of 3-6 MΩ when filled with the 
intracellular-like solution containing (mM): 130 K+-aspartate, 10 NaCl, 5 
EGTA-KOH, 2 CaCl2, 2 MgCl2, 2 ATP (Na
+-salt), 5 creatine phosphate, 0.1 
GTP (Na+-salt), 10 Hepes-KOH; pH 7.2. Temperature was kept at 36±1°C. 
Spontaneous action potentials were recorded in current-clamp mode using 
the whole-cell configuration.  Action potentials rate, Action Potential 
Duration at 50% of repolarization phase (APD50), Maximum Diastolic 
Potential (MDP) and the amplitude of the action potentials were analyzed. 
For voltage-clamp recordings, only single cells were used.  To dissect funny 
current (If) 1 mM BaCl2 and 2 mM MnCl2 were added to Tyrode. 
Hyperpolarizing test steps to the range -35/ -125 mV (10 mV increments) 
were applied from a holding potential of -30 mV, followed by a fully 
activating steps at -125 mV. Each test step was long enough to reach steady-
state current activation. Activation curves were obtained from normalized 
tail currents measured at -125 mV and fitted to the Boltzmann distribution: 
y= (1/(1+exp((V-V1/2)/s), where V is voltage, y fractional activation, V1/2 
the half-activation voltage, and s the inverse-slope factor (Figure 2A). For 
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L-type calcium current (ICaL) recordings, we used a 200 ms voltage ramp 
protocol from -60 mV to +60 mV (Figure 2B) into an extracellular solution 
containing (mM): CsCl 10, NaCl 135, CaCl2 1,  MgCl2 1, HEPES 5, Glucose 
11.1, Tetrodotoxin (TTX) 0.03, pH=7.4; To specifically block ICaL, 10µM 
Nifedipine was added and, then, ICaL was considered as the Nifedipine-
sensitive component. 
 
 
Figure 2. Voltage protocol used to record If (A) and ICaL current (B). 
 
 
  
A) 
B) 
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Results 
1. Nfix expression in the heart 
I. Nfix gene expression during cardiac development. 
To obtain detectable RNA during embryogenesis, different hearts samples 
for every time point considered were pulled together (embryonic day  E, 
number of hearts: E10.5-12.5: n=6; E14.5-16.5: n=4; postnatal day P, P1: 
n=3; P3: n=2; P5: n=2; P7: n=2; adult ventricle, AV, n=1). Plotting the 
expression level at the various time points, a time course of Nfix expression 
in the heart from mid-gestation to adulthood was obtained (Figure 1, A). Nfix 
transcript is not expressed at around E10.5 (2-ΔCt*100= 0.05, n=1). It displays 
an increase during development (E12.5: 2-ΔCt*100=0.66, n=1; E14.5: 2-
ΔCt*100=1.10, n=1; E16.5: 2-ΔCt*100=1.67, n=1) and a peak of expression 
after birth (P1: 2-ΔCt*100= 2.00±0.79, n=3; P3: 2-ΔCt*100= 2.74±0.60, n=3; 
P5: 2-ΔCt*100= 2.95±0.22, n=3). At P7 Nfix-mRNA expression stabilizes to 
the value (2-ΔCt*100= 3.36±0.37 n=3) that is maintained up to adulthood (2-
ΔCt*100=3.34±0.29, n=6).  
II. Nfix gene expression in the adult heart. 
Since Nfix transcript increases after birth, Nfix gene expression was 
investigated in the adult heart. In the adult mice, Nfix mRNA is not detected 
in Nfix-null tissues as expected, but it is in the heart, in the skeletal muscle 
and in the brain (Figure 1, B).  Nfix transcript is expressed in the atria (2-
ΔCt*100= 40.66±7.2, n=6) and ventricles (2-ΔCt*100= 48.37±5.30, n=6) to 
levels comparable to those of the tibialis muscle (2-ΔCt*100= 36.68±19.34, 
n=3) and hippocampus (2-ΔCt*100= 63.59±26.46, n=3). As evident from 
figure 1B, there are differences among the various cardiac regions: Nfix is 
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significantly less expressed in the SAN than ventricles and atria (2-
ΔCt*100=5.21±1.10*, n=6, *p<0.05 ANOVA Fisher’s LSD) (Fig.1, B).  
  
Figure 1.  A) Time course of Nfix-mRNA expression by qPCR during heart development 
(E= Embryonic Day; P= Post-Natal Day; AV= Adult Ventricles) B) Mean Nfix 
expression levels in the various regions of the heart (A= atria, V= ventricles, SAN= 
sinoatrial node) and in tibialis muscle (T), hippocampus (H) and Nfix-null ventricle (KO) 
for comparison. 
  
A) B) 
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2. Cardiac morphology of WT and Nfix-null mice 
Considering that Nfix-null mice are characterized by a reduced body size and 
distinctive skeletal defects (Campbell et al., 2008, Driller et al., 2007), we 
investigated the morphological characteristics of the heart of Nfix-null and 
WT mice. Histological analysis were performed on fixed heart sections 
obtained from 3-month-old Nfix-null (n=2) and WT mice (n=2). The sections 
were stained with either Hematoxylin&Eosin or Milligan’s trichrome stain 
to highlight the presence of necrosis, hypertrophy or fibrosis. No evident 
morphological differences between Nfix-null and WT emerged suggesting 
that the  structure of the heart is normal in the absence of NFIX (Fig. 
2A).Since NFIX plays a pivotal role in skeletal sarcomere organization 
(Messina et al., 2010), alterations of myocardium-specific genes were 
investigated by qPCR in atria and ventricles of adult WT and Nfix-null mice. 
We considered the expression of the sarcomeric genes troponin (cTnI), 
myosins (Mlc2v, Myh6 and Myh7) and of the transcription factor Nkx2.5, 
which is important for working myocardium commitment. As shown in 
figure 2B and in table 1, no statistical differences were found between the 
expression values of these genes in both atria and ventricles of Nfix-null and 
WT mice suggesting that sarcomere structure is not affected by the lack of 
NFIX protein.  
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Figure 2.  A) Histological sections of two WT and two Nfix-null hearts stained by either 
Hematoxylin and Eosin stain or Milligan’s Trichrome staining. Calibration bar=1 mm. 
B) Mean expression value of cardiac troponin I (cTnI), ventricular myosin light chain 2 
(Mlc2v), Myosin heavy chain 6 (Myh6), 7 (Myh7) and NK2 Homeobox 5 (Nkx2.5) genes 
in WT and Nfix-null atria and ventricles. 
A) 
B) 
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 WT 
ATRIA 
(n=3) 
Nfix-null  
ATRIA 
(n=3) 
WT 
VENTRICLES 
(n=3) 
Nfix-null 
VENTRICLES 
(n=3) 
cTnI 145.76± 19.79 143.57± 22.54 142.89± 30.14 135.28± 21.89 
Mlc2v 3.94±2.30 3.94±2.30 440.00±86.88 392.68±63.37 
Myh6 559.77±139.33 644.44±138.40 358.45±101.90 370.07±90.45 
Myh7 1.49±0.58 1.46±0.49 1.26±0.49 0.87±0.19 
Nkx2.5 2.20±0.77 2.75±0.39 1.25±0.25 1.37±0.22 
 
Table 1.  Mean expression value of cardiac troponin I (cTnI), ventricular myosin light 
chain 2 (Mlc2v), Myosin heavy chain 6 (Myh6), 7 (Myh7) and NK2 Homeobox 5 (Nkx2.5) 
genes in WT and Nfix-null atria and ventricles. All the mean values are expressed as 2-
ΔCt*100±S.E.M; Student T-test was used to perform statistical analysis. 
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3. NFIX loss increases intrinsic heart rate. 
We then evaluated the effect of the lack of NFIX on the cardiac function in 
6-month-old WT and Nfix-null mice were implanted with a radio transmitter 
and ECGs were recorded in freely moving conditions for 5 days. In Figure 
3A, representative traces of ECGs recorded of WT (green) and Nfix-null 
(blue) mice are shown, in which a tachycardia is clearly visible. In panel B, 
timecourse of mean heart rate of Nfix-null (n=4) and WT (n=5) mice during 
5 days of recordings are shown. Both WT and Nfix-null mice show a 
physiological increase of heart rate during night recordings following the 
circadian rhythm, but this change in rate is higher in Nfix-null 
(Δbpm=70±11.48*, n=16, *p=0.0006) than in WT (Δbpm=19.84±7.92, 
n=22) mice (Figure 3B). Moreover, Nfix-null shows a higher mean heart rate 
than WT both at night (WT: 496.70±13.07 bpm, n=22/5; Nfix-null: 
587.48±8.68 bpm, n=18/4) and during the day (WT: 466.98±8.42 bpm 
n=24/5; Nfix-null: 523.10±13.25 bpm, n=17/4)(Figure 3C).  
To understand if the in vivo tachycardia is an effect intrinsic of the pacemaker 
tissue or instead is due to a sympathetic hyperstimulation, pacemaker cells 
from the sinoatrial node (SANCs) were isolated for in vitro 
electrophysiological experiments. Representative trace of action potentials 
recorded in WT (green) and Nfix-null (blue) SANCs cells are depicted in 
Figure 4A. Nfix-null SANCs exhibit a higher firing rate (577.80±52.80 
bpm*, n=7,*p=0.02) than WT-SANCs (403.80±45.00 bpm, n=7) suggesting 
that in vivo-tachycardia is associated with an increased intrinsic heart rate, 
independent of the autonomic tone (Figure 4B). Action potential amplitude 
(APA), Maximum Diastolic Potential (MDP) and Action Potential Duration 
at 50% of repolarization (APD50) were analyzed but no statistical 
differences emerged between Nfix-null and WT-SANCs (Table 2). 
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Because of the limited number of Nfix-null mice, another in vitro cellular 
model was used to study the effect of NFIX loss on cardiac rate. Neonatal 
rat ventricular cardiomyocytes (NRVCs), cells that show spontaneous 
beating, (Scavone et al., 2013) were infected with a lentivirus with either a 
short hairpin that downregulated Nfix-mRNA (Nfix-sh) or a scrambled 
sequence (Scramble). Using non-infected NRVCs as a control, we 
demonstrated that Nfix-sh infection caused an 85.24±2.26% (n=18) 
downregulation of the Nfix transcript (Figure 5A). Representative traces of 
spontaneous action potentials of both Scramble (green) and Nfix-sh (blue) 
are shown in figure 5B. Nfix-sh NRVCs display a higher action potential 
firing rate (87.60±7.80 bpm*, n=20, p=0.041) than Scramble cells 
(54.00±9.00 bpm, n=19). No differences were found in APA, MDP and 
APD50 between Nfix-sh and Scramble as shown in Table 3. 
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Figure 3.  A) Representative ECGs traces recorded from freely moving WT (green) and 
Nfix-null (blue) mouse. B) Timecourse of mean heart rate of WT and Nfix-null mice 
during 5 days of recordings C) Mean heart rate of dark and light recordings of WT and 
Nfix-null mice. 
A) 
B) c) 
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Figure 4.  A) Representative spontaneous action potential traces of isolated WT and Nfix-null 
SANCs. B) Boxplot of mean action potential firing rate of WT and Nfix-null cells. 
 
 APA (mV) MDP (mV) APD50 (ms) 
WT (n=7) 79.15±12.44 -57.90±3.55 28.61±3.54 
Nfix-null (n=7) 75.66±5.35 -58.92±3.13 24.12±1.42 
Table 2. Spontaneous Action Potential parameters in Nfix-null and WT SANCs. 
A) B) 
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Figure 5.  A) Mean Nfix-transcript expression in Not Infected, Scramble and Nfix-sh NRVCs; 
ANOVA Fisher’s LSD, *p<0.05. B) Spontaneous action potentials recorded from Scramble 
(green) and  Nfix-sh (blue) NRVCs. C) Boxplot of APs firing rate in scramble and Nfix-sh 
NRVCs; Student’s T-test, *p<0.05. 
 APA (mV) MDP (mV) APD50 (ms) 
Scramble (n=19) 92.82±3.25 -59.22±1.75 107.68±5.92 
Nfix-sh (n=20) 93.45±3.25 -57.30±2.19 100.97±8.62 
Table 3. Spontaneous Action Potential parameters in Nfix-sh and Scramble NRVCs. 
  
A) B) 
C) 
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4. NFIX loss enhances CAV1.3- L-Type Calcium current but 
does not affect Funny current. 
Action potential firing originates from a combination of pacemaker currents 
involved during the diastolic depolarization of the action potential including 
the funny current (If) and L-type calcium current (ICaL). To clarify the role of 
these ion channels in Nfix-null mouse model’s tachycardia, we performed an 
analysis of the abundance of both the sinoatrial f-channels Hcn4 and the 
sinoatrial calcium channels isoforms in Nfix-null and WT SAN including L-
type (Cacna1c and Cacna1d) and T-type (Cacna1g and Cacna1h) calcium 
channels (Figure 6).  We found an upregulation of Hcn4 (Fig. 6A) and 
Cacna1d (Fig. 6B) transcript in Nfix-null (Hcn4: 2-ΔCt*100= 0.94±0.21*, 
n=5; Cacna1d: 2-ΔCt*100=1.45±0.40*, n=5) compared to WT (Hcn4: 2-
ΔCt*100=0.40±0.03, n=5; Cacna1d: 2-ΔCt*100=0.59±0.12, n=8) SAN tissues. 
For this reason, we perform an electrophysiological characterization of both 
funny and L-type calcium current in our cellular models of murine SANCs 
and NRVCs. In figure 7A and D, representative traces of recorded If in both 
SAN and NRVC cellular models are shown. In contrast of the apparent 
Hcn4-mRNA upregulation in Nfix-null SAN, there were no statistical 
differences in neither current density nor kinetics in WT vs Nfix-null cells 
(Figure 7B and C) and Scramble vs Nfix-sh NRVCs (Figure 7E and F)(Table 
4) suggesting that Nfix-null’s tachycardia is not caused by a gain-of-function 
of If current. Representative traces of Nifedipine-sensitive ICaL current from 
Scramble and Nfix-sh NRVCs revealed an increase of ICaL density current in 
Nfix-sh (Figure 8A). Nfix-sh exhibits a higher ICaL current density amplitude 
(at 0mV: -2.19±0.24, n=11) than Scramble (at 0mV: -1.42±0.19, n=5) 
NRVCs (Figure 8B). 
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Considering that only Cacna1d transcript was found to be upregulated in 
Nfix-null compared to WT SAN we hypothesize an increase of CaV1.3 L-
type calcium current in the knockout model that we would like to confirm in 
the next electrophysiological experiments in SANCs. 
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Figure 6.  Mean expression value of Hcn4 (A), L-type (Cacna1c and Cacna1d) and T-type 
(Cacna1g and Cacna1h) in WT and Nfix-null SAN tissue (B).   
  
Figure 7.  A&D) Representative traces of recorded funny current of WT vs Nfix-null 
SANCs (A) and Scramble and Nfix-sh infected NRVCs (D). B&E) Mean If current density 
vs voltages of WT vs Nfix-null SANCs (B) and Scramble and Nfix-sh infected NRVCs (E). 
C&F) Mean If activation curve of WT vs Nfix-null SANCs (C) and Scramble and Nfix-sh 
infected NRVCs (F). 
  
A) B) 
C) A) B) 
D) E) F) 
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  Current density at -125mV 
(pA/pF) 
Vhalf (mV) Slope 
WT -23.25±4.78 
(n=9) 
-79.19±2.29 
(n=15) 
10.85±0.64 
(n=15) 
Nfix-null -42.11±10.34 
(n=13) 
-75.42±2.10 
(n=14) 
10.15±0.67 
(n=14) 
Scramble -4.57±1.37 
(n=4) 
-75.78±1.63 
(n=9) 
7.55±0.89 
(n=9) 
Nfix-sh  3.92±0.80 
(n=5) 
-79.01±1.94 
(n=5) 
6.03±0.81 
(n=5) 
 
Table 4. If parameters analysis in SAN and NRVC cellular models. While for current 
density, only single cells were considered, for activation curve analysis even small groups 
of cells were included. 
 
Figure 8. A) Representative traces of recorded Nifedipine-sensitive ICaL in Scramble (green) and 
Nfix-sh (blue). B) Mean ICaL current density in Scramble and Nfix-sh. C) Mean expression value 
of 
 
  
A) B) 
64 
 
Discussion 
 
The Nuclear Factor I (NFI) transcription factor family (NFIA, NFIB, NFIC 
and NFIX) has many roles in animal physiology, biochemistry and pathology 
(Gronostajski et al., 2000). Gene deletion technologies elucidated the 
importance of these genes in several tissues such as brain, lungs, teeth, 
intestine, muscle and skeleton (das Neves et al., 1999, Campbell et al., 2008, 
Driller et al., 2007). Nfix-null mice exhibit several evident anomalies 
including reduced body size (Campbell et al., 2008, Driller et al., 2007), 
severe fiber disorganization of the skeletal muscle (Messina et al., 2010) and 
a reduced size of the cerebellum (Piper et al., 2011). Although, Nfix transcript 
has been demonstrated to be present in other tissues in the mouse (Chaudry 
et al., 1997), the full spectrum of functions of this transcription factor is still 
unclear. Recently, loss-of-function mutations of NFIX gene have been 
associated with the onset of rare overgrowth syndromes (Malan and 
Marshall-Smith syndromes) in humans that resemble for many aspects the 
Nfix knock-out mouse phenotype (Malan et al., 2010, Driller et al., 2007). 
For this reason, the interest about the role of this transcription factor is 
growing and needs to be unravelled.  
The first evidence about the role of NFIX has been gathered during the 
development of the brain and the skeletal muscle (Messina et al., 2010, 
Matuzelski et al., 2017). 
In the skeletal muscle, Messina and colleagues demonstrated that NFIX 
plays a pivotal role in the transcriptional switch from the primary embryonic 
muscle into a more mature and organized fetal muscle inhibiting the 
expression of the slow myosin heavy chain protein (Messina et al., 2010).  
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We demonstrated that in the heart, Nfix expression gradually increases 
during development reaching the peak of expression around birth and 
thereafter it is maintained in adulthood. The exponential increase of Nfix-
mRNA seems to parallel the increase of Myh6-mRNA and the decrease of 
Myh7-mRNA during the cardiac development as shown by Willie and 
colleagues (Willie et al., 1991). This evidence suggests that similarly to what 
happens during skeletal myogenesis, NFIX may participate in the 
transcriptional switch between Myh7 and Myh6 in the heart. However, we 
did not find evident cardiac alterations between WT and Nfix-null mice 
despite the defects in the skeletal muscle in Nfix-null mice (Messina et al., 
2010). 
In the adult mouse, it has been shown that NFIX promotes the regeneration 
process of the skeletal muscle after injury through the inhibition of the 
Myostatin pathaway (Rossi et al., 2016) and the neural stem cell 
differentiation in the hippocampus (Harris et al., 2018). In this study, we 
demonstrated that Nfix gene is expressed in the adult heart comparably to the 
tibialis muscle and the hippocampus. Notably, in the heart Nfix is highly 
expressed in the atria and the ventricles that constitute the working 
myocardium. The evidence that Nfix-mRNA is abundant in the working 
myocardium strengthens the idea that NFIX could regulate the expression of 
structural proteins important for the contraction activity of the heart. In the 
skeletal muscle, NFIX is able to modulate myosins promoter activity alone 
(Messina et al., 2010) or together with other transcription factors (Taglietti 
et al., 2016).  Contrarily , in the heart several genes that are specifically 
expressed in the working myocardium, such as cardiac troponin I (cTNI), 
atrial and ventricular specific myosins (MYH6, MYH7 and MLCV2) and the 
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transcription factor NKX2.5, do not show statistical differences of 
expression levels in WT and Nfix-null cardiac tissues. 
We observed that in the sinoatrial node (SAN), where the heartbeat 
originates, Nfix transcript, although present, is significantly less expressed 
than in the working myocardium. ECGs recorded from freely moving WT 
and Nfix-null mice indicated that the absence of the NFIX protein leads to 
tachycardia during both day and night, strongly suggesting a link to electrical 
alterations in the heart. It has been shown that transcription factors can be 
linked to electrical alterations in the heart. For example, several variants 
associated with atrial fibrillation appear in proximity of the PITX2 gene 
(Gudbjartsson et al., 2007) that encodes for a transcription factor essential 
for the transcriptional block of SAN development in the left atrium 
(Mommersteeg et al., 2008). 
To properly clarify the connection between in vivo tachycardia and NFIX 
loss, we considered that physiologically tachycardia could be caused by 
either an enhancement of the activity of the sympathetic nervous system or 
by an increase of the intrinsic heart rate in SAN. SAN cells isolated from 
Nfix-null mice display a higher action potential firing rate in comparison to 
WT-SANCs. These in-vitro experiments clearly demonstrate that in vivo 
tachycardia is not dependent on sympatho-vagal regulation, but rather a 
direct effect of the increase of intrinsic SANCs rate. To confirm this 
hypothesis and exclude sympatho-vagal involvement, in the next 
experiments we will also consider the heart rate variability from ECGs 
recordings. Furthermore, to investigate the NFIX-dependent tachycardia, 
RNA interference was performed on neonatal rat ventricular cardiomyocytes 
(NRVCs) to specifically silence Nfix gene. NRVCs are immature ventricular 
cardiomyocytes that maintain a spontaneous beating activity similarly to 
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pacemaker cells making them an attractive in-vitro cellular model 
(Campostrini et al., 2017, Scavone et al., 2013). Similarly to SANCs, Nfix-
silenced NRVCs (Nfix-SH) display an higher action potentials rate in 
comparison to scrambled-infected NRVCs (Scramble) confirming that NFIX 
is able to negatively modulate the intrinsic cellular rate. 
The reduction of the expression level of Nfix gene thus leads to an increase 
of action potential firing rate. Our hypothesis is that NFIX acts as a negative 
modulator of pacemaker activity and Nfix mRNA expression must be lower 
in the SAN than the working myocardium to allow pacemaking. This 
hypothesis is further confirmed by the analysis of Nfix-mRNA expression 
levels comparing adult mouse heart and NRVCs. NRVCs show a higher Nfix 
expression than SAN tissue but still lower than working myocardium (data 
not shown) suggesting that spontaneous beating activity of the immature 
myocytes disappears in the adult working myocardium because of the 
increase of Nfix transcription. 
Alterations of the physiological intrinsic heart rate can be explained by 
changing the slope of the slow diastolic depolarization phase which is 
primarily sustained by the Funny current (If) (DiFrancesco et al., 1986, 
Baruscotti et al., 2005, Barbuti et al., 2007) and/or ICaT and ICaL calcium 
currents (Mangoni et al., 2003, Mangoni et al., 2006, Mesirca et al., 2014). 
We investigated the expression levels of several sinoatrial ion channels 
involved in the diastiolic depolarization in WT and Nfix-null SAN tissues. 
We found that only Hcn4 and Cacna1d mRNAs were upregulated in the 
Nfix-null SAN. HCN4 is the most abundant HCN channel in SAN and it 
sustains the If current (Brioschi et al., 2009). In the literature, HCN4 
mutations have also been linked to alterations of heart rate including sinus 
bradycardia (Milanesi et al., 2006) and tachycardia (Baruscotti et al., 2017). 
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Baruscotti and collegues, for example, demonstrated also that Hcn4-KO 
mouse model display deep bradycardia due to If decrease in SAN (Baruscotti 
et al., 2011). Moreover, cardiomyocytes derived from the differentation of 
HCN4-overexpressing mouse embryonic stem cells (mESCs) show an 
enhancement of the spontaneous beating activity when compared with the 
WT mESCs (Saito et al., 2015). Neither Nfix-null- SAN cells nor Nfix-SH-
infected NRVCs exhibit any significant differences in If   kinetics or current 
density amplitudes when compared to their respective controls suggesting 
that HCN channels are not potential targets of NFIX activity.  
The T-type calcium channels genes for CAV3.1 (Cacna1g) and CAV3.2 
(Cacna1h) do not display any differences in their expression levels in Nfix-
null and WT SAN tissues suggesting T-type calcium channels are not 
affected by NFIX regulation. The L-type calcium channels genes for 
CAV1.2 (Cacna1c) and CAV1.3 (Cacna1d) were also considered. We did 
not find any differences in Cacna1c expression in Nfix-null and WT SAN 
but Cacna1d was upregulated in Nfix-null SAN. Since CAV1.3 is the 
predominant L-type calcium channel isoform in SAN tissue and it gives the 
greater contribution to pacemaking mechanisms (Christel et al., 2012, Gao 
et al., 2011), NFIX-dependent action potential rate increase can be caused 
by an upregulation of L-type calcium current. Mangoni et al. showed that 
CAV1.3 KO SAN cells display a 60% reduction of ICaL amplitude and slower 
action potential firing rate than WT SANCs (Mangoni et al., 2001, Mangoni 
et al., 2003, Rose et al., 2011). Furthermore, global CAV1.3 KO induces 
bradycardia and atrioventricular block in mouse model (Platzer et al., 2000, 
Marger et al., 2011). Electrophysiological experiments to study ICaL 
amplitude and kinetics have not been performed in Nfix-null and WT SAN 
cells yet, but we demonstrated that ICaL current density amplitude in Nfix-SH 
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NRVCs is higher than in Scramble NRVCs. The evidence that alterations in 
CAV1.3 channels modulate SAN rate is in accordance with the idea that a 
gain of function of CAV1.3 may consequently cause tachycardia. In 
conclusion, here we demonstrated for the first time that NFIX is not only 
expressed in the adult heart, but it also acts as a negative regulator of cardiac 
automaticity, presumably affecting CAV1.3 channels expression. In the 
skeletal muscle, Messina and colleagues consider NFIX as the key regulator 
of transcriptional switch from embryonic to fetal myogenesis. However, we 
discover a new potential role of NFIX in development. Our data suggest that 
the activation of the transcription of Nfix gene after birth is not a coincidence 
but rather a pivotal event for transition from pacemaking into not-
pacemaking tissue during cardiac development. 
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